November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Rick Buck: Vivek Subbiah on Leveraging Social Media for Professional Growth and Networking
Oct 9, 2024, 09:37

Rick Buck: Vivek Subbiah on Leveraging Social Media for Professional Growth and Networking

Rick Buck, Chief Communications Officer/Vice President of Communications and Public Relations at AACR, shared on X:

“My friend and partner in cancer research social media Vivek Subbiah⁩ is presenting on Leveraging Social Media for Professional Growth and Networking at the ⁦AACR Grantee Summit. Thank you for rearranging your schedule to present today!”

Vivek Subbiah

More posts featuring Vivek Subbiah on oncodaily.com

Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.